|
Volumn 25, Issue 10, 2004, Pages 1513-1515
|
Comparison of intravenous aminoglycoside therapy with switch therapy to cefixime in urinary tract infections
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
AMINOGLYCOSIDE;
AMPICILLIN;
ANTIBIOTIC AGENT;
CEFIXIME;
CEFTRIAXONE;
CEPHALOSPORIN;
GENTAMICIN;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACTERIUM CULTURE;
BLOOD CULTURE;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST CONTROL;
DRUG COST;
DRUG EFFICACY;
DRUG MECHANISM;
ESCHERICHIA COLI;
HEALTH CARE COST;
HOSPITAL INFECTION;
HOSPITALIZATION;
HUMAN;
HYPERTENSION;
KIDNEY DYSFUNCTION;
KLEBSIELLA;
MORBIDITY;
PRACTICE GUIDELINE;
PYELONEPHRITIS;
RANDOMIZED CONTROLLED TRIAL;
RISK REDUCTION;
SIDE EFFECT;
TREATMENT OUTCOME;
URINALYSIS;
URINARY TRACT INFECTION;
ADOLESCENT;
AGE FACTORS;
AMINOGLYCOSIDES;
CEFIXIME;
CEFOTAXIME;
CHILD;
CHILD, PRESCHOOL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MAXIMUM TOLERATED DOSE;
PROSPECTIVE STUDIES;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
URINALYSIS;
URINARY TRACT INFECTIONS;
|
EID: 7244245746
PISSN: 03795284
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (20)
|
References (5)
|